Abstract

Background
Antibiotic treatment recommendations based on susceptibility data from routinely submitted urine samples may be biased because of variation in sampling, laboratory procedures, and inclusion of repeat samples, leading to uncertainty about empirical treatment.
Aim
To describe and compare susceptibilities of E. coli cultured from routinely submitted samples, with E. coli causing UTI from a cohort of systematically sampled, acutely unwell children.
Design, setting and participants
Susceptibilities of 1458 E. coli isolates submitted during the course of routine primary care for children <5 years (routine care samples), compared to susceptibilities of 79 E. coli isolates causing UTI from 5107 children <5years presenting to primary care with an acute illness (systematic sampling: the DUTY cohort).
Results
The percentage of E. coli sensitive to antibiotics cultured from routinely submitted samples were; amoxicillin 45.1% (95% CI 42.5% to 47.7%); co-amoxiclav using the lower systemic breakpoint (BP) 86.6% (84.7% to 88.3%); cephalexin 95.1% (93.9% to 96.1%); trimethoprim 74.0% (71.7% to 76.2%); and nitrofurantoin 98.2% (97.4% to 98.8%)..
Introduction
Early, effective antibiotic treatment of UTI in young children alleviates acute symptoms, and may also limit long-term sequelae.(1) Antibiotics should ideally be prescribed only to those who have a UTI, using an antibiotic with the narrowest effective spectrum. Empirical treatment is more or less universal in primary care, given that urine culture results take several days, and as yet there are no rapid point of care tests that give a sufficiently robust indication of aetiology and the susceptibility of infecting organisms.
Guidelines generally recommend that choice of empiric antibiotics for suspected urinary tract infection (UTI) in acutely unwell children should depend on local susceptibilities.(1, 2) Such information is usually derived from routinely collected data, and may provide biased estimates because of variation in sampling decisions by individual clinicians, differing laboratory procedures and the inclusion of repeat samples in databases. The susceptibilities of organisms from urines submitted in routine care and in organisms causing UTI from systematically obtained urines in primary care have not been directly compared.
Information about susceptibilities of cultured organisms in urine samples routinely submitted from children in primary care may therefore not be generalizable to the child presenting with acute illness in primary care who has not had recurrent UTIs, who is not known to have a structural renal tract abnormality, or who has complex medical needs. Previous studies have generally focused on epidemiological studies of asymptomatic children (3) (4) (5) (6) or on children presenting to health care with symptoms clearly attributable to UTI.(7) A recent study from the US found that the resistance patterns differed between routinely submitted outpatient and inpatient urine samples. (8) We know of only one large study that has focused on culture results in systematically sampled acutely unwell children, and we know of no study that has analysed systematically sampled urine from acutely unwell children in a central research laboratory using more intensive techniques that are currently undertaken in routine laboratory practice.(9) Susceptibilities of organisms cultured in systematically sampled children in the community with an acute illness (not just those suspected of UTI) have not been compared to sensitivities in urines submitted for routine laboratory culture (which usually includes only those children with a high suspicion of UTI, recurrent UTI and with renal tract abnormalities). Systematic sampling involves taking a urine sample form all eligible children rather than sampling based only clinical suspicion. Such a comparison would help determine the applicability of findings surveillance based on routinely submitted samples to children presenting in primary care with an acute illness.
We therefore set out to compare the susceptibilities of E. coli in samples positive for UTI in routinely submitted samples from children in the community and compare these to those cultured from systematically obtained samples considered positive for UTI in acutely unwell pre-school children presenting to primary care.
Methods
Samples submitted during the course of routine care
Antimicrobial susceptibility data for urines submitted to microbiology laboratories across Wales in 2011 was extracted from DataStore, a data repository that extracts all results from the laboratory information management systems into a common searchable format. DataStore was searched for all urines submitted from general practice from children in the first five years of life with an E. coli UTI (identified directly using UTI Chromogenic agar) that had susceptibility testing performed from any of the 10 laboratories in Wales. Culture and susceptibilities were performed using common standard operating procedures, based on the National Standard Method (BSOP 41).(10) Susceptibilities were performed by BSAC disc diffusion tests. (12) The data do not differentiate between mid-stream, clean-catch, nappy pad or catheter urines. Data from duplicate isolates were removed prior to analysis. Organisms from the same patient, with the same identification and susceptibility pattern isolated ≤ 91 days from the date of the initial isolate were excluded. To reduce the effect of variable susceptibility testing rates to different antibiotics, individual hospital or laboratory sensitivities are only presented for organisms where ≥80% of such isolates from the given sample type was tested and where the number of isolates tested exceeds 10. In the case of first generation cephalosporins, eight laboratories reported cephalexin and two laboratories cefradine. For the purposes of this analysis the results have been combined and reported as cephalexin. For co-amoxiclav a systemic breakpoint (BP) was used for interpretation. We were not able to obtain culture results for urine submitted UK wide.
Samples from children undergoing systematic urine sampling (The DUTY Cohort)
The Diagnosis of Urinary Tract infection in Young children (DUTY) study was a multicentre, prospective, diagnostic cohort study that recruited children aged under 
DUTY Cohort Participants
Children presenting unwell to primary care with an acute illness episode of up to 28 days duration, even where the responsible clinician was confident of the diagnosis (e.g. a child with bronchiolitis), or with urinary symptoms, were eligible to take part in the study. The sample therefore included all children with an acute illness, not just those at high risk of UTI. Children were excluded if: they were neither constitutionally unwell (e.g. acute conjunctivitis only) or an absence of urinary symptoms; they were known to have a neurogenic or surgically reconstructed bladder; they were using a permanent or intermittent urinary catheter; the main presenting problem was trauma; or antibiotics had been taken within seven days.
DUTY cohort procedure
Urine samples were obtained by clean catch, where possible, for children who were toilet trained or for whom the parent or DUTY Study Research Nurse was happy to attempt collection. For children still using nappies (diapers) whose parents did not think clean catch would be successful, Newcastle Nappy Pads were used. Nappy pads were inserted into the nappy (diaper) then removed as soon as the child urinated to reduce the risk of contamination. Once the child had urinated the nappy pad was removed and the urine was extracted with a syringe into a sterile container.
If it was not possible to obtain a sample before the child left the primary care site, the parent was given the necessary equipment and advice on taking the sample at home.
They were given a labelled Sterilin™ bottle into which to transfer the urine, and asked to write the time and date the sample was obtained. They were advised to store the sample in the refrigerator and return it to the primary care site (directly or via collection by the DUTY Study Research Nurse/Clinical Studies Officer) as soon as possible, preferably within 24 hours.
DUTY cohort laboratory analysis
Urine samples were split into two fractions. Since results might be needed for clinical management, the priority fraction was sent to the local NHS laboratory routinely used by the recruiting primary care site for routine diagnostic processing. If sufficient urine was available, the second fraction was sent to the Specialist Antimicrobial clavulanate. The BSAC method was the most used method in the UK whilst the EUCAST method is the method due to be adopted by UK labs in the future. In this study, we used both discs to cover any differences that may be highlighted.
Urinary breakpoints are employed when the UTI is uncomplicated, as in most adult community patients. Systemic breakpoints are used when the UTI may be more complicated (i.e. causing a systemic infection). In the DUTY children we thought it advisable to interpret using both breakpoints to cover the possibility that a system infection could be present.
The definition of UTI in the Central Research Laboratory was ≥10 5 CFU/mL of a pure or predominant uropathogen (where predominant was defined as a 3 log10 difference in growth between the predominant and next organism). For the purposes of the DUTY study, an uropathogen is defined as any Enterobacteriaceae. We used the cut point of ≥10 5 CFU/mL to reduce risk of including false positives.
Results
Samples submitted during the course of routine care
In the routine database analysis, we identified 1458 urine samples for children in the first five years of life in 2011 that were submitted from general practices in the course of routine care, which grew E. coli and were tested for antimicrobial susceptibility (only 1343 were tested against amoxicillin). We do not have data for the total number of samples that were submitted for children in this age group, only those growing E. 
Systematically sampled dataset (DUTY cohort)
A total of 6390 urine samples were obtained from the 7163 recruited children. 
Discussion
Urine sampling rates from primary care are variable and may be biased towards recurrent and more severe cases, and so antibiotic susceptibilities from routinely submitted samples may not be representative of organisms causing urinary tract infection (UTI) in children presenting with acute illness in the course of routine care, and this may bias treatment recommendations that are based on routinely submitted samples. We found that the antimicrobial susceptibilities of organisms considered to be causing a UTI cultured in routinely submitted samples was remarkably similar to susceptibilities of organisms considered to be causing a UTI cultured from urine in systematically sampled children under the age of five. Most UTIs in preschool children remain susceptible to nitrofurantoin, co-amoxiclav (using the urinary BP in uncomplicated UTI), and cephalexin.
Our systematically sampled data set was obtained from the largest prospective study of UTI in children presenting to primary care with acute illness. We recruited large numbers and had over 5000 centrally analysed urine results. All of these urine samples were processed according to the same standard operating procedures, and cultured using sensitive methods. This suggests that estimates of antimicrobial susceptibilities derived from surveillance using routinely submitted samples from young children are applicable to empirical treatment decision for acutely unwell children in primary care.
Resistance to trimethoprim in E. coli from both systematically sampled urines and routine care urines was between 26% and 29%. This is equivalent to the proportion trimethoprim resistance in E. coli from a UK multicentre study (26.7%) in 2003. (21) However trimethoprim resistance levels may vary depending on locality; a report 
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